secwatch / observer

Quantum-Si Inc — fact timeline

Source-grounded facts extracted from Quantum-Si Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

QSI Quantum-Si Inc JSON
Shareholder Votes

Quantum-Si Inc shareholders approved Advisory vote on executive compensation at the 2026-05-15 meeting.

“The advisory vote of the compensation of the Company’s named executive officers, as described in the Proxy Statement, was approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 441,315,119 13,004,700 226,840 48,912,907”
Shareholder Votes

Quantum-Si Inc shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-05-15 meeting.

“The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 502,452,749 756,904 249,913 48,912,907”
Shareholder Votes

Quantum-Si Inc shareholders approved Election of Directors at the 2026-05-15 meeting.

“The following nominees were reelected to serve on the Board until the Company’s 2027 annual meeting of stockholders, based on the following votes: Name Votes For Votes Against Votes Abstained Broker Non-Votes Charles Kummeth 450,934,026 3,431,426 181,207 48,912,907”
Earnings Releases

Quantum-Si Inc reported the first quarter ended March 31, 2026 results: revenue $258,000, net income $21.7 million.

“For the first quarter of 2026, the Company recorded revenue of $258,000. Gross profit was $74,000 and gross margin was 29%. Total operating expenses were $24.1 million in the first quarter of 2026, compared to $25.6 million for the same period in the prior year. Adjusted total operating expenses were $21.4 million in the first quarter of 2026 compared to $22.9 million for the same period in the prior year.”
Restructurings & Charges

Quantum-Si Inc announced a restructuring with charges of approximately $2.3 million in 2024 and another $0.3 million in the first six months of 2025 (approximately 23% of its 187-employee workforce).

“On November 21, 2024, Quantum-Si Incorporated (the “Company”) committed to an organizational restructuring program designed to streamline and focus its overall corporate resources, as well as align required resources to focus on future product development objectives, including its recently announced Proteus TM platform. As a result, the Company is terminating approximately 23% of its 187-employee workforce. In connection with the restructuring, the Company expects that it will recognize one-time cash charges related to severance and other benefits of approximately $2.3 million in 2024 and another $0.3 million in the first six months of 2025. In addition, the Company expects to recognize non-cash expense over the remainder of 2024 in the amount of approximately $0.2 million related to stock option modifications.”

Todd Bennett was appointed as Chief Commercial Officer at Quantum-Si Inc.

“The Company has appointed Todd Bennett as the Company’s new Chief Commercial Officer, effective as of September 17, 2024.”

Grace Johnston resigned as Chief Commercial Officer at Quantum-Si Inc.

“On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.”

Jonathan M. Rothberg changed role as Chairperson of the Board at Quantum-Si Inc.

“the Company’s current Chairperson of the Board, Jonathan M. Rothberg, Ph.D., continues to serve as a director of the Company but ceased serving as Chairperson of the Board.”

Charles Kummeth was appointed as Chairperson of the Board at Quantum-Si Inc.

“On May 27, 2024, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) elected Charles (“Chuck”) Kummeth to the Board and appointed him as Chairperson of the Board, each effective as of May 27, 2024”
Governance Changes

Quantum-Si Inc: Amended certificate of incorporation to remove director cap and add automatic conversion of Class B common stock on June 10, 2028 (effective 2024-05-16).

“On May 16, 2024, Quantum-Si Incorporated (the “Company”) filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to (i) remove the cap on the number of directors to serve on the Company’s board of directors (the “Board”) and make related changes to the process for filling newly created directorships or board vacancies (the “Director Cap Amendments”), and (ii) add a provision with respect to the automatic conversion of the Company’s Class B common stock effective June 10, 2028, which is seven years from the date of the closing of the business combination by and among Quantum-Si Incorporated (formerly HighCape Capital Acquisition Corp.), Tenet Merger Sub, Inc., and Q‐Si Operations Inc. (formerly Quantum-Si Incorporated) (the “Sunset Amendment” and together with the Director Cap Amendments, the “Charter Amendment”).”
Shareholder Votes

Quantum-Si Inc shareholders approved Sunset Amendment at the 2024-05-15 meeting.

“The Sunset Amendment was approved, based on the following votes: Class A Common Stock: Votes For Votes Against Votes Abstained Broker Non-Votes 61,429,495 254,661 80,694 - Class B Common Stock: Votes For Votes Against Votes Abstained Broker Non-Votes 398,750,000 - - -”
Shareholder Votes

Quantum-Si Inc shareholders approved Director Cap Amendments at the 2024-05-15 meeting.

“The Director Cap Amendments were approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 460,048,611 401,937 64,302 -”
Shareholder Votes

Quantum-Si Inc shareholders approved Advisory vote to approve named executive officer compensation at the 2024-05-15 meeting.

“The advisory vote of the compensation of the Company’s named executive officers, as described in the Proxy Statement, was approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 459,462,890 907,087 144,873 -”
Shareholder Votes

Quantum-Si Inc shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm at the 2024-05-15 meeting.

“The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 460,397,267 71,110 46,473 -”
Earnings Releases

Quantum-Si Inc reported first quarter ended March 31, 2024 results: revenue $457,000, net income -$19.5 million (net loss of $19.5 million). Guidance reaffirmed.

“the “Company”), The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights ● Reported revenue of $457,000 in the first quarter of 2024 ● Commenced its full commercial launch of its Platinum ® instrument at the end of March 2024 ● On track to launch version 3 of its sequencing kit,”

Paula Dowdy was appointed as Director at Quantum-Si Inc.

“the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Paula Dowdy to the Board, effective as of March 21, 2024.”
Earnings Releases

Quantum-Si Inc reported the full year ended December 31, 2023 results: revenue $1.1 million, net income $96.0 million. Guidance initiated.

“For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%. The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits. Total operating expenses were $28.1 million in the fourth quarter of 2023, compared to $38.8 million for the same period in the prior year, and $111.7 million for the full year ended December 31, 2023, compared to $123.8 million for the same period in the prior year. Adjusted total operating expenses were $26.3 million in the fourth quarter of 2023, compared to $25.3 million for the same period in the prior year, and adjusted total operating expenses for the full year ended December 31, 2023, were $98.9 million compared to $103.2 million for the same period in the prior year. Overall adjusted operating expenses for 2023”
Earnings Releases

Quantum-Si Inc reported the fourth quarter ended December 31, 2023 results: revenue $400,000, net income $22.0 million. Guidance initiated.

“During the fourth quarter of 2023, the Company continued its controlled commercial launch of its Platinum instrument, recording revenue of $400,000. Gross profit was $178,000 and gross margin was 45%. For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%. The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits. Total operating expenses were $28.1 million in the fourth quarter of 2023, compared to $38.8 million for the same period in the prior year, and $111.7 million for the full year ended December 31, 2023, compared to $123.8 million for the same period in the prior year. Adjusted total operating expenses were $26.3 million in the fourth quarter of 2023, compared to $25.3 million for the same period in the prior year, and adjust”
Earnings Releases

Quantum-Si Inc reported the third quarter ended September 30, 2023 results: revenue revenue of $223,000, net income Net loss was $24.7 million.

““Company”), The Protein Sequencing Company TM , today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights ● Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum instrument ● Completed a strategic review of”

Amir Jafri was appointed as Director at Quantum-Si Inc.

“On September 15, 2023, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Amir Jafri to the Board, effective as of September 22, 2023.”

Patrick Schneider was terminated as President and Chief Operating Officer at Quantum-Si Inc.

“Pursuant to the Separation Agreement, Dr. Schneider’s employment with the Company terminated on August 31, 2023 (the “Separation Date”).”
Restructurings & Charges

Quantum-Si Inc announced a restructuring with charges of approximately $2.5 million affecting organizational restructuring (approximately 16% of its workforce).

“with the restructuring, the Company expects that it will recognize over the remainder of 2023 a one-time cash charge related to severance and other benefits of approximately $2.5 million. In addition, the Company expects to recognize non-cash expense over the remainder of 2023 in the amount of approximately $0.3 million related to stock option modifications. The”

Jeffrey Hawkins was appointed as President at Quantum-Si Inc.

“the Company’s board of directors (the “Board”) appointed Jeffrey Hawkins, the Company’s current Chief Executive Officer and member of the Board, as President of the Company, effective as of the Effective Date.”

Patrick Schneider departed as President and Chief Operating Officer at Quantum-Si Inc.

“On August 28, 2023 (the “Effective Date”), the Company and Patrick Schneider, Ph.D. , the Company’s current President and Chief Operating Officer, mutually determined that Dr. Schneider w ill step down from such roles, effective as of the Effective Date.”
Earnings Releases

Quantum-Si Inc reported second quarter ended June 30, 2023 results: revenue $205,000, net income $25.6 million. Guidance reaffirmed.

““Company”), The Protein Sequencing Company TM , today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights ● Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum TM instruments. ● Strengthened the Board of Directors with the addition of Scott Mendel”

Michael P. McKenna changed role as Executive Vice President, Product Development and Operations at Quantum-Si Inc.

“As previously disclosed, Dr. McKenna will transition out of his role as of July 31, 2023.”

Michael P. McKenna, Ph.D. departed as Executive Vice President, Product Development and Operations at Quantum-Si Inc.

“mutually determined that Dr. McKenna will step down from such role, effective as of July 31, 2023.”

Claudia Drayton departed as Chief Financial Officer and Treasurer at Quantum-Si Inc.

“Ms. Drayton stepped down as Chief Financial Officer and Treasurer of the Company on May 12, 2023”

Jack Kenny was appointed as Director at Quantum-Si Inc.

“appointed John Patrick (“Jack”) Kenny to the Board, effective as of May 19, 2023.”
Governance Changes

Quantum-Si Inc: Certificate of Amendment to Second Amended and Restated Certificate of Incorporation to limit officer liability as permitted by recent Delaware law amendments (effective 2023-05-12).

“On May 12, 2023, Quantum-Si Incorporated (the “Company”) filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to limit the liability of its officers as permitted by recent amendments to Delaware law (the “Charter Amendment”).”
Shareholder Votes

Quantum-Si Inc shareholders approved Approval of Charter Amendment at the 2023-05-11 meeting.

“4. The Charter Amendment was approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 444,981,936 6,546,723 94,876 26,472,991”
Shareholder Votes

Quantum-Si Inc shareholders approved Advisory vote on executive compensation at the 2023-05-11 meeting.

“3. The advisory vote of the compensation of the Company’s named executive officers, as described in the Proxy Statement, was approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 446,045,206 5,457,383 120,946 26,472,991”
Shareholder Votes

Quantum-Si Inc shareholders approved Ratification of selection of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-05-11 meeting.

“2. The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 477,398,042 552,225 146,259 0”
Shareholder Votes

Quantum-Si Inc shareholders approved Election of directors at the 2023-05-11 meeting.

“1. The following nominees were reelected to serve on the Company’s board of directors until the Company’s 2024 annual meeting of stockholders, based on the following votes: Name Votes For Votes Against Votes Abstained Broker Non-Votes Jonathan M. Rothberg, Ph.D. 437,306,196 14,217,615 99,724 26,472,991 Jeffrey Hawkins 448,380,055 3,138,725 104,755 26,472,991 Ruth Fattori 450,912,510 592,624 118,401 26,472,991 Brigid A. Makes 448,868,316 2,605,805 149,414 26,472,991 Michael Mina, M.D., Ph.D. 446,743,033 4,747,756 132,746 26,472,991 Kevin Rakin 441,503,020 10,009,359 111,156 26,472,991 Scott Mendel 451,036,366 469,682 117,487 26,472,991”
Earnings Releases

Quantum-Si Inc reported first quarter ended March 31, 2023 results: revenue $254,000, net income $23.6 million.

“a filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 brhc20052637_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Quantum-Si Reports First Quarter 2023 Financial Results Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8% This was the Company’s first quarter of revenue generated on the sale of Platinum TM instruments and kits Expect revenue to accelerate”

Claudia Drayton departed as Chief Financial Officer and Treasurer at Quantum-Si Inc.

“the Company and Claudia Drayton , the Company’s current Chief Executive Officer and Treasurer, mutually determined that Ms. Drayton w ill step down from such roles, effective as of the Appointment Date”

Jeffry Keyes was appointed as Chief Financial Officer and Treasurer at Quantum-Si Inc.

“On May 2, 2023, Quantum-Si Incorporated (the “Company”) announced that Jeffry Keyes was appointed by the Board of Directors of the Company (the “Board”) as Chief Financial Officer and Treasurer of the Company, effective on the date he commences employment with the Company on or before May 15, 2023 (the “Appointment Date”).”
Earnings Releases

Quantum-Si Inc reported the fourth quarter and full year ended December 31, 2022 results: net income Net loss was $33.1 million in the fourth quarter of 2022, compared to a net loss of $29.4 million in the fourth quarter.

“On March 6, 2023, Quantum-Si Incorporated (the “Company”) issued a press release announcing its results for the fourth quarter and full year ended December 31, 2022 and providing a business update.”
Restructurings & Charges

Quantum-Si Inc announced a restructuring with charges of up to $1.0 m illion (approximately 12% of its workforce).

“On January 30, 2023, Quantum-Si Incorporated (the “Company”) committed to an organizational restructuring designed to decrease its costs and create a more streamlined organization to support its business. As a result, the Company is terminating approximately 12% of its workforce, effective in the first quarter of 2023. In connection with the restructuring, the Company currently estimates it will incur up to $1.0 m illion of costs, consisting primarily of cash severance costs and other severance benefits.”
Earnings Releases

Quantum-Si Inc reported third quarter ended September 30, 2022 results: net income Net loss was $31.7 million. Guidance lowered.

“On November 7, 2022, Quantum-Si Incorporated (the “Company”) issued a press release announcing its results for the third quarter ended September 30, 2022 and providing a business update.”

Jonathan Rothberg changed role as Interim Chief Executive Officer at Quantum-Si Inc.

“Jonathan Rothberg, Ph.D., who has been serving as Interim Chief Executive Officer of the Company, will step down from that role effective as of the Appointment Date”

Jeffrey Hawkins was appointed as director at Quantum-Si Inc.

“the Board also approved an increase in the size of the Board from seven to eight members and appointed Mr. Hawkins to fill the newly created vacancy, effective as of the Appointment Date”

Vikram Bajaj was appointed as Director at Quantum-Si Inc.

“appointed Vikram Bajaj, Ph.D. to the Board, effective as of June 15, 2022.”

Matthew Dyer resigned as Chief Business Officer at Quantum-Si Inc.

“On June 9, 2022, Matthew Dyer, Ph.D. delivered his resignation as Quantum-Si Incorporated’s (the “Company”) Chief Business Officer, effective as of June 15, 2022”

Patrick Schneider was appointed as President and Chief Operating Officer at Quantum-Si Inc.

“on May 9, 2022, the Company announced that Patrick Schneider was appointed by the Board as President and Chief Operating Officer of the Company, effective as of May 9, 2022.”

Michael P. McKenna changed role as Executive Vice President, Product Development and Operations at Quantum-Si Inc.

“the Board of Directors (the “Board”) of the Company approved a title change for Michael P. McKenna, Ph.D., from President and Chief Operating Officer of the Company to Executive Vice President, Product Development and Operations of the Company, effective as of May 6, 2022”

Jonathan M. Rothberg, Ph.D. was appointed as Interim Chief Executive Officer at Quantum-Si Inc.

“On February 8, 2022, the Board appointed Jonathan M. Rothberg, Ph.D. as Interim Chief Executive Officer of the Company, effective as of February 8, 2022, to succeed Mr. Stark while the Company searches for Mr. Stark’s replacement.”

John Stark resigned as Chief Executive Officer at Quantum-Si Inc.

“Effective February 8, 2022, John Stark delivered his resignation as Quantum-Si Incorporated’s (the “Company”) Chief Executive Officer and a member of the Board of Directors (the “Board”) in order to pursue opportunities outside of the Company.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.